Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Graft-versus-host disease prophylaxis with abatacept plus intermediate dose cyclophosphamide for GVHD prophylaxis after peripheral blood stem transplantation: a single institution study.
Journal: Bone marrow transplantation
Published: May 21, 2026
Treatment of TP53-mutated myelodysplastic syndrome and acute myeloid leukemia with lowintensity metronomic decitabine and venetoclax.
Journal: Haematologica
Published: January 13, 2026
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases.
Journal: JCO precision oncology
Published: July 25, 2025
Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia.
Journal: Haematologica
Published: December 23, 2024
Use of the IgG degrader imlifidase for a poorly desensitized patient undergoing haematopoietic stem cell transplantation with donor-specific antibodies.
Journal: British journal of haematology
Published: November 15, 2024
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study.
Journal: JMIR cancer
Published: October 28, 2024
Inter-racial genetic differences in myelofibrosis: a diverse inner-city center analysis.
Journal: Leukemia & lymphoma
Published: October 21, 2024
Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification.
Journal: Blood cancer journal
Published: October 17, 2024
Last Updated: 09/26/2026